TLR4 and breast carcinoma: Recently, Wang et al. have reported that Resistin promotes breast cancer metastasis and stemness through Toll-like receptor 4 (TLR4) signaling, suggesting TLR4 as a receptor for Resistin-mediated breast cancer progression (43).